SpaceX and Tesla plan Texas “Terafab” with $55 billion initial investment, total seen rising to $119 billion

AI Market Summary
SpaceX's proposed Texas "Terafab" semiconductor megafacility, with reported investment up to $119bn, signals aggressive vertical integration aimed at securing compute for Musk-linked technologies (Tesla robotics/autonomy and SpaceX infrastructure). If realized, it could tighten Tesla's strategic positioning in AI/compute supply chains and boost US advanced-manufacturing narrative, though timelines, execution, and funding remain key uncertainties.
Impact level
● Medium
Affected assets
NCSKTSLA2USD/USDT+0.49%
AI Insight · NCSKTSLA2USD/USDTAI Insight
● Neutral
Trade now
⚠️ AI-generated insights are based on news content and are provided for informational purposes only. They do not constitute investment advice or represent the views of BingX. Investing involves risk. Please trade responsibly.
SpaceX is planning a “Terafab” manufacturing complex in Texas with an initial investment of $55 billion, with total spending potentially rising to $119 billion if additional phases are completed. The proposed facility is designed to include more than 100 million square feet of manufacturing space and an internal volume estimated at about 100 million cubic metres. That would put it far ahead of the Boeing Everett Factory, currently the world’s largest building by volume.